Benitec Biopharma raises target price to $20 from $17
BNTC•Wedbush raised its target price for Benitec Biopharma to $20 from $17.
Related News

Axe Compute Q3 revenue soars sequentially
AGPU•

Manhattan Associates named a leader in Gartner Magic Quadrant for distributed order management
MANH•

QT Imaging attends 17th annual Craig-Hallum Alpha Select Conference
QTI•

Canadian housing starts fall less than expected in October
SPY•

PureCycle participates in PepsiCo sustainability innovation hub in Mexico City
PCT•